metformin aurobindo 1000 mg tabletki powlekane
aurobindo pharma limited - metformini hydrochloridum - tabletki powlekane - 1000 mg
symformin xr 500 mg tabletki o przedłużonym uwalnianiu
symphar sp. z o.o. - metformini hydrochloridum - tabletki o przedłużonym uwalnianiu - 500 mg
symformin xr 1000 mg tabletki o przedłużonym uwalnianiu
symphar sp. z o.o. - metformini hydrochloridum - tabletki o przedłużonym uwalnianiu - 1000 mg
sitagliptin dz 25 mg tabletki powlekane
day zero ehf. - sitagliptinum - tabletki powlekane - 25 mg
sitagliptin dz 100 mg tabletki powlekane
day zero ehf. - sitagliptinum - tabletki powlekane - 100 mg
sitagliptin teva 25 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - sitagliptinum - tabletki powlekane - 25 mg
sitagliptin teva 50 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - sitagliptinum - tabletki powlekane - 50 mg
sitagliptin teva 100 mg tabletki powlekane
teva pharmaceuticals polska sp. z o.o. - sitagliptinum - tabletki powlekane - 100 mg
sitagliptin dz 50 mg tabletki powlekane
day zero ehf. - sitagliptinum - tabletki powlekane - 50 mg
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.